Run time: 57m

  0      0

On-Demand eCasts

21EL-642 On-Demand eCast: Donor Hemovigilance During the COVID-19 Pandemic

Expiration Date: Jun 2, 2024

Credits: None available.


Live Program Date: Wednesday, June 2, 2021
Program Number: 21EL-642

Educational Track: Scientific
Topics: Blood Donation & Collection, COVID-19, Hemovigilance, Infectious Diseases, Patient Transfusion, Research
Intended Audience: CEOs, Directors, Donor Recruitment Staff, Hospital Blood Banks, Medical Directors, Research Scientists, Residents/Fellows, Students (MD, MT, SBB)
Teaching Level: Basic, Intermediate

(titles and affiliations at the time of the live program)
Director: Srijana Rajbhandary, MPH, Associate Director, AABB, Bethesda, MD
Moderator: Nancy L. Van Buren, MD, Medical Director, Innovative Blood Resources, division of New York Blood Center, St. Paul, MN
Speakers: Joseph Cho, MD, PhD, Transfusion Medicine Fellow, Versiti Blood Center of Wisconsin, Milwaukee, WI; Maha Al-Ghafry, MD, Transfusion Medicine Fellow, New York Blood Center, NY; Richard R. Gammon, MD, Medical Director, OneBlood, Orlando, FL

Program Description
Ensuring donor safety is of paramount importance to our community. During this program, the speakers will share results from the recently conducted COVID-19 Convalescent Plasma (CCP) Donor Hemovigilance Multicenter Study. The study was conducted to evaluate the safety of CCP donation and to determine whether CCP donors have a higher incidence of donor adverse events (DAE) compared to conventional plasma donors. In addition, the speakers will provide an overview of the responses made by blood centers during the COVID-19 pandemic to ensure donor safety, develop CCP programs, discuss their approach to winding down the CCP collections, and strategies for converting first-time CCP donors to the regular donor pool.

Learning Objectives
After participating in this educational activity, participants should be able to:

  • Describe the most common donor adverse events (DAEs) among CCP donors.
  • Discuss the differences in demographics and DAEs among CCP donors and conventional plasma donors.
  • Give example(s) of common protocols for CCP donor programs and collection practices during the COVID-19 pandemic.

How to Claim Continuing Education Credit

  • Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.
  • Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.





  • 1.00 - General Continuing Education (GEN)
  • 1.00 - Florida Lab Personnel (FLP)
  • 1.00 - California Lab Personnel (CLP)

You must be logged in and own this session in order to post comments.